Search

Chinese
Resource Library / Hugh Davis for Contract Pharma

video

Hugh Davis for Contract Pharma

Check out Frontage's CBO, Hugh Davis, PhD, interview with Contract Pharma about Frontage's range of services and its expansion into biologics and early development capabilities.

Resource Preview

Resources to Consider

Left arrow
Gene Therapy Podcast with Hugh Davis
podcast

Gene Therapy Podcast with Hugh Davis
In this podcast, Hugh Davis, Chief Business Officer at Frontage Laboratories, discusses ho...
Access Resource
Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes
poster

Validation of a 384 gene hybridization capture-based pharmacogenomics...
​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly deter...
Access Resource
Testing of Carryover & After MRD Benchtop Stability for Pharmacokinetic Method Validation in Gyrolab Immunoassay Platform
white-paper

Testing of Carryover & After MRD Benchtop Stability for...
In this white paper, we show testing of two critical parameters for the method validation ...
Access Resource
Sequencing Assays for Biomarker Discovery and Pharmacodynamics in Oncology Studies eBook
ebook

Sequencing Assays for Biomarker Discovery and Pharmacodynamics in...
In this eBook, we navigate the landscape of biomarker discovery through genomic profiling,...
Access Resource
Rapid, accurate and highly customizable assay platforms for pharmacogenomic studies
webinar

Rapid, accurate and highly customizable assay platforms for...
The diagnosis and treatment of human diseases and the development of new drugs increasingl...
Access Resource
Microbiological Testing Considerations for Pharmaceutical Products
webinar

Microbiological Testing Considerations for Pharmaceutical Products
In this webinar, speaker Christopher Gilmer introduces microbiological testing for raw mat...
Access Resource
Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using the Simoa HD-X platform
poster

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...
Alzheimer’s disease (AD) is a neurodegenerative disorder which stands as one of the most...
Access Resource
Nonclinical Vehicle Formulations:HP-β-CD (Hydroxypropyl-Beta-Cyclodextrin) & The Risk of Hemolysis
poster

Nonclinical Vehicle Formulations:HP-β-CD...
Beta-cyclodextrin is a commonly used excipient in nonclinical vehicle formulations. In a r...
Access Resource
Evaluating the feasibility of lyophilization for oral formulation development of monoclonal antibodies (mAbs)​
poster

Evaluating the feasibility of lyophilization for oral formulation...
Objective: To develop a stable lyophilized non-invasive oral formulation of monoclonal ant...
Access Resource
Companion Diagnostics for Alzheimer’s Disease
poster

Companion Diagnostics for Alzheimer’s Disease
Method Validation of Phospho-Tau217 (pTau-217) Quantitation Using the Quanterix Simoa™ ...
Access Resource
Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids
poster

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...
This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and...
Access Resource
Development and validation of an LC-MS/MS method for the quantification of fascin proteins in human serum
journal

Development and validation of an LC-MS/MS method for the...
Fascin is an actin-bundling protein that has been linked to tumor cell migration, invasion...
Access Resource
Right arrow